Nobiletin Inhibits Cell Viability via the SRC/AKT/STAT3/YY1AP1 Pathway in Human Renal Carcinoma Cells - Wei, D; Zhang, G; Zhu, Z; Zheng, Y; Yan, F; Pan, C (Front Pharmacol, 2019)